Notice: You are only receiving the textual content of this site, most likely because you are using an outdated web browser that does not support a web technology called CSS. To also receive this site's layout and design, please upgrade to a browser that supports web standards.


Jump to Navigation

cni » personnel » david tate

David F. Tate, PhD

Co-Director, Center for Neurological Imaging

group

Permanent Staff

specialties

Clinical neuroscience, HIV, imaging, image analysis

languages

English


phone

+1 (617) 525-6282

personal page

[none]


info

Dr. David Tate earned his bachelor's degree in psychology and anthropology and his doctoral degree in clinical psychology with a neuropsychology emphasis from Brigham Young University in Provo, Utah. Dr. Tate completed his predoctoral residency in neuropsychology within the Clinical Psychology Training Consortium at Brown Medical School. His post-doctoral training was at The Miriam Hospital in Providence, RI where he completed an NIH/NIDA T32 (DA-13911; Prevention, Diagnosis, and Treatment of HIV and Other Infectious Diseases Among Substance Abusers) fellowship studying the cognitive effects of HIV infection. Dr. Tate joined the faculty at Brown Medical School for one year where he was an Assistant Professor of Research in the Department of Psychiatry and Behavioral Medicine. Currently, Dr. Tate is a research associate of radiology at the Brigham and Women's Hospital and a lecturer at Harvard University Medical School. He is also on the faculty at the Boston University School of Medicine as an adjunct faculty member in the Department of Neurology.

Dr. Tate's research interest has been focused on the interface of state of the art medical imaging (MRI) and behavior. Dr. Tate has participated in several large studies of different neurological diseases, injury, and developmental disorders including Alzheimer's disease, carbon monoxide poisoning, traumatic brain injury, Autism, HIV infection, cardiovascular disease, and post-traumatic stress disorder. Common to each of these studies was the use of structural and functional MRI methods to examine changes in the brain associated with these various neurological disorders and the association these changes have with cognitive performance, behavior, and/or mood. Currently, Dr. Tate has funding to examine three different patient populations using MRI and cognitive testing (HIV, normal aging controls, and mild cognitive impairment). Efforts in these studies are aimed at understanding the evolution and progression of structural imaging changes and how well these changes can be used to examine clinical outcomes in these different patient populations.




CNI/BWH © 2000–2008 | XHTML 1.0-T, CSS